feedback
facebook page
Follow Me on Pinterest
twitter page
google plus page
rss feed

Recalled Product

Item detail and remedy information

Search Recalls or Browse by Category
Consumer Products (?)
Food & Health (?)
Vehicles (?)
Home > Recalled Products > Drugs > Undetermined Hazard > Taytulla Birth Control Capsules

Recall: Taytulla Birth Control Capsules

email
email

On 2018-05-29, the FDA announced that Allergan is conducting a recall on Birth Control Capsules due to a possible undetermined hazard. The recalled products were sold under the brand name(s) Taytulla during an unspecified time period throughout the regions shown in the map below.

In recent months, there have been 1 drugs recalls due to potential undetermined hazard, including acyclovir tablet, usp, 400mg, 50ct unit dose, intralipid 20% iv fat emulsion, 100 ml and more. Additionally, there have been 29 drug and medical device recalls due to other health hazards as well as 100 food recalls.

Email Me About Recalls On:
Food  |  Drugs  |  Medical Devices  |  Pet Care Products  |  All of These


Correctly Packaged TAYTULLA Image
Note: Images may not be available for every version. Please review the detailed description below.

Company Contact Information:

Name: Allergan
Website: http://www.taytulla.com/
Phone: 800-678-1605

Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.

Detailed Recall Information



Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.

Product Description: Birth control capsules

Brand Name(s): Taytulla

Reason for Recall: Undetermined Hazard

Official Recall Date: 2018-05-29


Advertisement

Additional information provided by the FDA.gov:

Allergan plc (NYSE:AGN) today issued a voluntary recall in the US market of one lot (Lot# 5620706, Expiry May-2019) of TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) 1mg/20mcg, 6x28 physicians sample pack, indicated for use by women to prevent pregnancy. Allergan recently identified, through a physician report, that four placebo capsules were placed out of order in a sample pack of TAYTULLA. Specifically, the first four days of therapy had four non-hormonal placebo capsules instead of active capsules. Read More.


More information may be available at FDA.gov
Advertisement


Latest Safety Recalls

Select image for details, including additional styles.

 

Advertisement

Comments

Do you have comments or questions about this recall? Share them here.
Note: The recalling companies may not be monitoring these comments; they should be directed toward the public. Community Guidelines apply.
comments powered by Disqus
Back to Top



Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.

Search Recalled Products or Browse by Category
Consumer Products (?)
Food & Health (?)
Vehicles (?)
Latest Product Recalls
Consumers
Register Products
Check for Recalls
Find Resources
Brands & Retailers
Connect to Customers

Consignment Sales
Check Inventory
Install Recall Finder
Take Safety Pledge

Home Inspectors
Check Appliances
Developers
APIs & Feeds
Recall Search for Web
Recall Search for Mobile
Facebook Apps

Researchers
Product Recall Statistics
About
Company
Contact
Press
Blog

Social
Facebook
Twitter